Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial D-1145-2016

Prime Capsules, 500mg, 60-count bottles, Distributed By Zagonfly 3129 25th St. #392 Columbus, IN 47203

Publicado el 13 de julio de 2016 · Inicio del retiro: 15 de diciembre de 2015

Resumen

FDA registra el retiro D-1145-2016 de medicamentos de Clase I, publicado el 13 de julio de 2016 e iniciado el 15 de diciembre de 2015. Empresa responsable: Bee Extremely Amazed LLC; Estado: Finalizado; Cantidad reportada: 1,104 bottles; Lote: All lots. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.

Qué hacer

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Bee Extremely Amazed LLC
Distribuidor
Nationwide
Lote
All lots
Clasificación de riesgo
Class I
Área (FDA)
drug
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Prime Capsules, 500mg, 60-count bottles, Distributed By Zagonfly 3129 25th St. #392 Columbus, IN 47203 fue retirado del mercado?

Sí. FDA publicó el retiro D-1145-2016 el 13 de julio de 2016. Peligro reportado: Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit